Advanced Silk Protein Fragment Generation and Biomaterial Fabrication

Publication ID: 24-11857663_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Advanced Silk Protein Fragment Generation and Biomaterial Fabrication,” Published Technical Disclosure No. 24-11857663_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857663_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,663.

Summary of the Inventive Concept

This inventive concept envisions a next-generation system for generating silk protein fragments with tunable molecular weights and fabricating biomaterials with programmable properties, enabling the creation of advanced silk-based medical devices, wound dressings, and implants.

Background and Problem Solved

The original patent disclosed stable silk protein fragment compositions, but the current inventive concept addresses the limitations of those compositions by introducing a system that can generate silk protein fragments with tailored molecular weights and polydispersity, enabling the creation of advanced biomaterials with specific properties.

Detailed Description of the Inventive Concept

The new inventive concept comprises a system with multiple modules, including a processing module, a control module, a computer-aided design module, and a fabrication module. The processing module receives raw silk material and outputs silk protein fragments with predetermined polydispersity and molecular weight ranges. The control module adjusts processing parameters to achieve desired fragment characteristics. The computer-aided design module designs silk protein fragment structures with desired properties, and the fabrication module assembles the fragments into a biomaterial with the desired properties. This system enables the generation of silk-based nanofibers, implantable devices, and wound dressings with tailored properties.

Novelty and Inventive Step

The new claims introduce a paradigm shift in silk protein fragment generation and biomaterial fabrication by enabling the creation of programmable biomaterials with specific properties. This is a significant departure from the original patent, which focused on stable silk protein fragment compositions. The inventive concept's ability to generate silk protein fragments with tunable molecular weights and fabricate biomaterials with programmable properties is new and non-obvious.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different processing techniques, such as enzymatic digestion or chemical modification, to generate silk protein fragments with tailored properties. Additionally, the system could be adapted for use with other biomaterials, such as collagen or chitin, to create a range of programmable biomaterials.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device and biomaterials industries, with potential applications in wound healing, tissue engineering, and implantable devices. The ability to create programmable biomaterials with specific properties could revolutionize the field of biomaterials and enable the creation of new medical devices and treatments.

CPC Classifications

SectionClassGroup
A A61 A61K8/64
A A45 A45D33/00
A A61 A61K8/02
A A61 A61K8/0216
A A61 A61K8/042
A A61 A61K8/19
A A61 A61K8/27
A A61 A61K8/29
A A61 A61K8/365
A A61 A61K8/4953
A A61 A61K8/676
A A61 A61K8/735
A A61 A61K8/922
A A61 A61K8/97
A A61 A61K8/9789
A A61 A61K8/9794
A A61 A61K8/987
A A61 A61K9/08
A A61 A61K31/375
A A61 A61K38/00
A A61 A61K38/012
A A61 A61K45/06
A A61 A61K47/02
A A61 A61K47/12
A A61 A61K47/36
A A61 A61Q17/04
A A61 A61Q19/00
A A61 A61Q19/007
A A61 A61Q19/02
A A61 A61Q19/08
C C07 C07K1/12
C C07 C07K14/43586
A A61 A61K2800/591
A A61 A61K2800/72
A A61 A61K2800/74
A A61 A61K2800/75

Field of Art

Biomaterials and protein engineering, with specific focus on silk protein processing and biomaterial fabrication, encompassing medical device development, tissue engineering, and advanced material design

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degrees in materials science, bioengineering, or chemical engineering, possessing expertise in protein modification, biomaterial processing, and understanding of molecular weight manipulation techniques

Obviousness Rationale

A PHOSITA would recognize that the PTD's system for generating silk protein fragments with tunable molecular weights represents a predictable extension of the source patent's teachings on silk protein fragment compositions. The fundamental techniques of molecular weight control, solvent processing, and biomaterial fabrication are well-established in the field, making the PTD's variations obvious incremental improvements rather than truly novel innovations.

Obvious Combinations & Variations

Source Patent Element
Lyophilized silk fibroin protein fragments with specific molecular weight ranges (17-45 kDa)
PTD Variation
Processing module for generating silk protein fragments with predetermined polydispersity and molecular weight ranges
Obviousness Reasoning
A PHOSITA would recognize that controlling molecular weight is a standard technique in protein engineering, and the PTD merely systematizes an existing known approach to fragment generation
Source Patent Element
Reconstituted silk fibroin protein fragments solution that does not spontaneously gelate
PTD Variation
Computer-aided design module for designing silk protein fragment structures with desired properties
Obviousness Reasoning
Computational design of protein structures is a predictable application of known computational biology techniques to extend the stability and functionality of protein fragments
Source Patent Element
Silk protein compositions with inorganic and organic residuals
PTD Variation
Fabrication module for assembling silk protein fragments into biomaterials with programmable properties
Obviousness Reasoning
Assembling protein fragments into advanced biomaterials is a logical progression of existing materials science techniques, representing a routine design optimization
Source Patent Element
Silk protein fragments suitable for medical applications
PTD Variation
Silk-based nanofibers, implantable devices, and wound dressings with tailored properties
Obviousness Reasoning
Creating specialized medical devices from silk proteins is an obvious application of known biomaterial processing techniques, representing a predictable extension of existing medical material design
Source Patent Element
Stable silk protein fragment compositions
PTD Variation
System for generating silk protein fragments with tunable molecular weights and programmable biomaterial properties
Obviousness Reasoning
The systematic approach to protein fragment generation represents an obvious optimization of existing protein processing techniques, utilizing standard engineering design principles
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857663 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed innovations obvious and therefore unpatentable. The systematic approach to silk protein fragment generation and biomaterial fabrication represents a predictable application of known techniques in protein engineering and materials science, lacking the requisite non-obviousness for patent protection.

Original Patent Information

Patent NumberUS 11,857,663
TitleStable silk protein fragment compositions
Assignee(s)EVOLVED BY NATURE, INC.